Free Trial

Biofrontera (BFRIW) Competitors

$0.14 -0.01 (-8.80%)
As of 08/29/2025

BFRIW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BTMDW, BCTXW, and CALA

Should you be buying Biofrontera stock or one of its competitors? The main competitors of Biofrontera include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

Biofrontera vs. Its Competitors

Biofrontera (NASDAQ:BFRIW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$39.19MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
180 Life Sciences Neutral

Summary

Biofrontera beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Biofrontera News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BFRIW vs. The Competition

MetricBiofronteraDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.69B$5.77B$9.76B
Dividend YieldN/A2.93%6.66%4.49%
P/E RatioN/A106.3682.3726.60
Price / SalesN/A1,454.65525.54161.29
Price / CashN/A10.3725.7028.92
Price / BookN/A11.2510.646.56
Net IncomeN/A$20.70B$3.28B$266.04M
7 Day Performance-8.80%0.79%0.10%-0.89%
1 Month Performance-11.70%5.75%8.91%4.34%
1 Year PerformanceN/A4.28%48.38%24.06%

Biofrontera Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BFRIW
Biofrontera
N/A$0.14
-8.8%
N/A+201.8%$0.00$39.19M0.0070
ATNFW
180 Life Sciences
N/A$0.23
-11.3%
N/A+1,961.9%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.30
-14.3%
N/AN/A$0.00$110.87K0.0040Positive News
ALVOW
Alvotech
N/A$1.18
+3.5%
N/A-56.1%$0.00$560.10M0.004Positive News
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.04
-20.9%
N/A-6.5%$0.00N/A0.0015
BTMDW
biote
N/A$0.01
+22.1%
N/A-96.2%$0.00$199.07M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.03
+31.0%
N/A-88.0%$0.00N/A0.008Short Interest ↓
CALA
Calithera Biosciences
N/A$0.00
-50.0%
N/A-99.5%$0.00N/A0.0060

Related Companies and Tools


This page (NASDAQ:BFRIW) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners